2-165748837-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004482.4(GALNT3):c.1846G>T(p.Val616Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000219 in 1,459,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V616M) has been classified as Uncertain significance.
Frequency
Consequence
NM_004482.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALNT3 | NM_004482.4 | c.1846G>T | p.Val616Leu | missense_variant | 11/11 | ENST00000392701.8 | |
GALNT3 | XM_005246449.2 | c.1846G>T | p.Val616Leu | missense_variant | 11/11 | ||
GALNT3 | XM_011510929.2 | c.1846G>T | p.Val616Leu | missense_variant | 11/11 | ||
GALNT3 | XM_017003770.2 | c.1846G>T | p.Val616Leu | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALNT3 | ENST00000392701.8 | c.1846G>T | p.Val616Leu | missense_variant | 11/11 | 1 | NM_004482.4 | P1 | |
GALNT3 | ENST00000409882.5 | c.1060G>T | p.Val354Leu | missense_variant | 8/8 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248402Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134400
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459696Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 726158
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 09, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with GALNT3-related conditions. This variant is present in population databases (rs769052242, ExAC 0.005%). This sequence change replaces valine with leucine at codon 616 of the GALNT3 protein (p.Val616Leu). The valine residue is highly conserved and there is a small physicochemical difference between valine and leucine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at